Methyldopa in the Treatment of Hypertension
- 2 February 1963
- Vol. 1 (5326), 295-300
- https://doi.org/10.1136/bmj.1.5326.295
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- [alpha-Methyl-DOPA. Therapeutic experiences in hypertension and biochemical research on its mode of action].1962
- Clinical and Chemical Studies with α -Methyl-Dopa in Patients with HypertensionCirculation, 1962
- In‐Vivo Decarboxylation of α‐Methyl DOPA and α‐Methyl MetatyrosineActa Physiologica Scandinavica, 1962
- Agranulocytosis caused by methyl dopa (Aldomet).1961
- Preliminary report on trial of l-alpha-methyl dopa (Aldomet) in the treatment of hypertension.1961
- [Guanethidine in the treatment of arterial hypertension].1961
- Decarboxylase Inhibition and Blood Pressure Reduction by α-Methyl-3,4-Dihydroxy-DL-phenylalanineScience, 1960
- A simple analysis for normetanephrine and metanephrine in urineClinica Chimica Acta; International Journal of Clinical Chemistry, 1960
- [Inhibition of DOPA decarboxylase by alpha-methyl-DOPA in vivo].1958
- Inhibition of dihydroxyphenylalanine decarboxylase by derivatives of phenylalanineArchives of Biochemistry and Biophysics, 1954